NIH-Led Consortium Will Help FDA Design Cardiac Resuscitation Trials
This article was originally published in The Gray Sheet
Executive Summary
Seven regional centers will collaborate on trials of cardiopulmonary resuscitation therapies as part of a Resuscitation Research Consortium supported by NIH
You may also be interested in...
Velomedix Pursues Cardiac Arrest Hypothermia Indication
Device start-up Velomedix plans to pursue the first FDA approval to use therapeutic hypothermia specifically to improve outcomes for cardiac arrest patients in the emergency room.
Velomedix Pursues Cardiac Arrest Hypothermia Indication
Device start-up Velomedix plans to pursue the first FDA approval to use therapeutic hypothermia specifically to improve outcomes for cardiac arrest patients in the emergency room.
Zoll Shifts Focus From Defib To Perfusion For Cardiac Emergency Market
Forthcoming American Heart Association guidelines on emergency cardiac resuscitation will spur demand for Revivant's AutoPulse, according to Zoll Medical